US Patent Issued to NANJING SANHOME PHARMACEUTICAL on Nov. 18 for "Substituted tricyclic compound as PRMT5 inhibitor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,280, issued on Nov. 18, was assigned to NANJING SANHOME PHARMACEUTICAL Co. LTD. (Jiangsu, China).

"Substituted tricyclic compound as PRMT5 inhibitor and use thereof" was invented by Yong Wang (Jiangsu, China), Liwen Zhao (Jiangsu, China), Xu Quan (Jiangsu, China), Guochuang Zheng (Jiangsu, China), Wei Sun (Jiangsu, China), Tingting Yang (Jiangsu, China), Kangning Zhan (Jiangsu, China) and Qiqi Shi (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the field of medicinal chemistry and relates to a class of substituted tricyclic compounds as PRMT5 inhibitors and the use thereof. Specifically, the present in...